XML 43 R28.htm IDEA: XBRL DOCUMENT
v3.10.0.1

Stock-Based Awards | 12 Months Ended
--- | ---
Jan. 26, 2019
Disclosure of Compensation Related Costs, Share-based Payments [Abstract] |
Stock-Based Awards | Stock-Based Awards The Company has outstanding stock-based awards under its 2003 Long-Term Incentive Plan, 2007 Non-Employee Directors Equity Plan, 2012 Long-Term Incentive Plan, and 2017 Non-Employee Directors Equity Plan (collectively, the “Plans”). No further awards will be granted under the 2003 Long-Term Incentive Plan or 2007 Non-Employee Directors Equity Plan. As of January 26, 2019, the total number of shares available for grant under the Plans was 1,201,611. Stock-based compensation expense and the related tax benefit recognized during fiscal 2019, the 2018 transition period, fiscal 2017, and fiscal 2016 were as follows (dollars in thousands):
| Fiscal Year Ended |  | Six Months Ended |  | Fiscal Year Ended
| January 26, 2019 |  | January 27, 2018 |  | July 29, 2017 |  | July 30, 2016
Stock-based compensation | $ | 20,187 |  |  | $ | 13,277 |  |  | $ | 20,805 |  |  | $ | 16,850 |
Recognized tax benefit of stock-based compensation | $ | 5,043 |  |  | $ | 4,793 |  |  | $ | 7,996 |  |  | $ | 6,436 |
In addition, the Company realized approximately $0.2 million, $7.8 million, $8.4 million, and $13.0 million of excess tax benefits, net of tax deficiencies, during fiscal 2019, the 2018 transition period, fiscal 2017, and fiscal 2016, respectively, related to the vesting and exercise of share-based awards. Excess tax benefits, net of tax deficiencies, represent cash flows realized from tax deductions in excess of the recognized tax benefit of stock-based compensation. As of January 26, 2019, the Company had unrecognized compensation expense related to stock options, RSUs, and Performance RSUs (based on the Company’s expected achievement of performance measures) of $2.5 million, $9.0 million, and $16.7 million, respectively. This expense will be recognized over a weighted-average number of years of 2.2, 2.4, and 1.0, respectively, based on the average remaining service periods for the awards. As of January 26, 2019, the Company may recognize an additional $10.3 million in compensation expense in future periods if the maximum amount of Performance RSUs is earned based on certain performance measures being met. The following table summarizes the valuation of stock options and restricted share units granted during fiscal 2019, the 2018 transition period, fiscal 2017, and fiscal 2016 and the significant valuation assumptions:
| Fiscal Year Ended |  | Six Months Ended |  | Fiscal Year Ended
| January 26, 2019 |  | January 27, 2018 |  | July 29, 2017 |  | July 30, 2016
Weighted average fair value of RSUs granted | $ | 97.90 |  |  | $ | 87.34 |  |  | $ | 79.04 |  |  | $ | 72.41 |
Weighted average fair value of Performance RSUs granted | $ | 106.19 |  |  | $ | 84.13 |  |  | $ | 79.29 |  |  | $ | 77.86 |
Weighted average fair value of stock options granted | $ | 48.19 |  |  | $ | 42.60 |  |  | $ | 39.90 |  |  | $ | 45.13 |
Stock option assumptions: |  |  |  |  |  |  |
Risk-free interest rate | 2.7 | % |  | 2.3 | % |  | 2.3 | % |  | 2.0 | %
Expected life (in years) | 6.3 |  |  | 7.6 |  |  | 7.6 |  |  | 7.3 |
Expected volatility | 43.3 | % |  | 43.4 | % |  | 44.7 | % |  | 55.0 | %
Expected dividends | — |  |  | — |  |  | — |  |  | — |
Stock Options The following table summarizes stock option award activity during fiscal 2019:
| Stock Options
| Shares |  | Weighted Average Exercise Price |  | Weighted Average Remaining Contractual Life (In years) |  | Aggregate Intrinsic Value (In thousands)
Outstanding as of January 27, 2018 | 636,730 |  |  | $ | 27.93 |  |  |  |  |
Granted | 28,796 |  |  | $ | 106.19 |  |  |  |  |
Options exercised | (82,235 | ) |  | $ | 10.59 |  |  |  |  |
Canceled | — |  |  | $ | — |  |  |  |  |
Outstanding as of January 26, 2019 | 583,291 |  |  | $ | 34.24 |  |  | 4.4 |  | $ | 17,785 |
Exercisable options as of January 26, 2019 | 512,871 |  |  | $ | 26.43 |  |  | 3.9 |  | $ | 17,785 |
The total amount of exercisable options as of January 26, 2019 presented above reflects the approximate amount of options expected to vest. The aggregate intrinsic values presented above represent the total pre-tax intrinsic values (the difference between the Company’s closing stock price of $59.18 on the last trading day of fiscal 2019 and the exercise price, multiplied by the number of in-the-money options) that would have been received by the option holders had all option holders exercised their options on the last trading day of fiscal 2019. The amount of aggregate intrinsic value will change based on the price of the Company’s common stock. The total intrinsic value of stock options exercised was $5.7 million, $4.5 million, $7.8 million, and $15.0 million for fiscal 2019, the 2018 transition period, fiscal 2017, and fiscal 2016, respectively. The Company received cash from the exercise of stock options of $0.9 million, $0.7 million, $1.4 million, and $2.7 million during fiscal 2019, the 2018 transition period, fiscal 2017, and fiscal 2016, respectively. RSUs and Performance RSUs The following table summarizes RSU and Performance RSU award activity during fiscal 2019:
| Restricted Stock
| RSUs |  | Performance RSUs
| Share Units |  | Weighted Average Grant Price |  | Share Units |  | Weighted Average Grant Price
Outstanding as of January 27, 2018 | 133,896 |  |  | $ | 71.81 |  |  | 390,327 |  |  | $ | 80.52 |
Granted | 62,477 |  |  | $ | 97.90 |  |  | 218,628 |  |  | $ | 106.19 |
Share units vested | (63,230 | ) |  | $ | 65.49 |  |  | (173,139 | ) |  | $ | 79.84 |
Forfeited or canceled | (6,673 | ) |  | $ | 70.56 |  |  | (58,462 | ) |  | $ | 75.34 |
Outstanding as of January 26, 2019 | 126,470 |  |  | $ | 87.92 |  |  | 377,354 |  |  | $ | 96.51 |
The total amount of granted Performance RSUs presented above consists of 158,841 target shares and 59,787 supplemental shares. During fiscal 2019, the Company canceled 24,689 supplemental shares of Performance RSUs, as a result of performance criteria for attaining those supplemental shares being partially met for the applicable performance periods. Approximately 23,384 target shares and 15,385 supplemental shares outstanding as of January 26, 2019 will be canceled during the three months ended April 27, 2019 as a result of the fiscal 2019 performance period criteria being partially met. The total amount of Performance RSUs outstanding as of January 26, 2019 consists of 273,219 target shares and 104,135 supplemental shares. The total fair value of restricted share units vested during fiscal 2019, the 2018 transition period, fiscal 2017, and fiscal 2016 was $15.3 million, $37.7 million, $33.2 million, and $39.1 million, respectively.

X
- Definition The entire disclosure for compensation-related costs for equity-based compensation, which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details and employee stock purchase plan details. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -URI http://asc.fasb.org/topic&trid=2228938 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 50 -URI http://asc.fasb.org/subtopic&trid=2208855 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration